drugset / Trial / NCT07538206
Vebectotamab Vedotin Combined With Pucotelimab in the Treatment of Locally Advanced Laryngeal Carcinoma
NaSingle-groupOpen-labelTreatment
Summary
This is a prospective, single-arm, Phase II clinical trial designed to evaluate the efficacy and safety of vibecotamab combined with putelimab in the treatment of locally advanced laryngeal carcinoma.
Timeline
- Start
- 2026-04-23
- Primary completion
- 2031-04-23
- Completion
- 2031-04-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Putilimab | Unknown | — | — |
| Subject | Vibecotamab | Monoclonal antibody | — | — |